ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 984,93
-0,99%
Dow Jones
37 903,29
0,23%
DAX
17 932,17
-1,10%
Brent Oil
83,555
0,02%
Bitcoin
57 133,02
-1,90%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Forte Biosciences Inc (FBRX)

  7. Forte Biosciences Inc (FBRX) Actualités

FBRX Forte Biosciences Inc

0,6794
-0,06185 (-8,34%)
02 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Forte Biosciences Inc FBRX NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,06185 -8,34% 0,6794 00:31:12
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,7285 0,6301 0,768 0,671 0,74125
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
16/2/202422:16EDGAR2Form 8-K/A - Current report: [Amend]
14/2/202422:54EDGAR2Form SC 13G - Statement of acquisition of beneficial..
05/1/202423:27EDGAR2Form SC 13D/A - General statement of acquisition of..
03/1/202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202316:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202300:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202301:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/12/202301:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/12/202322:05EDGAR2Form 8-K - Current report
22/11/202323:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/10/202322:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202322:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/9/202322:16EDGAR2Form 8-K/A - Current report: [Amend]
20/9/202323:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/9/202323:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/9/202323:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/9/202323:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/9/202323:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/9/202322:15EDGAR2Form 8-K - Current report
20/9/202322:05EDGAR2Form 8-K - Current report
14/9/202322:00EDGAR2Form DFAN14A - Additional definitive proxy soliciting..
14/9/202316:50BWISS and Glass Lewis Recommend Forte Biosciences Stockholders..
11/9/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
08/9/202322:36EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
06/9/202322:31EDGAR2Form DFAN14A - Additional definitive proxy soliciting..
06/9/202321:15BWConcerned Stockholders of Forte Biosciences and Its..
01/9/202323:25EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
31/8/202323:29EDGAR2Form DFAN14A - Additional definitive proxy soliciting..
31/8/202320:31EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
29/8/202323:57EDGAR2Form S-3 - Registration statement under Securities Act of..
25/8/202323:17EDGAR2Form DFAN14A - Additional definitive proxy soliciting..
25/8/202316:10EDGAR2Form DEFC14A - Definitive proxy statement, contested..
25/8/202314:00BWConcerned Stockholders of Forte Biosciences File Definitive..
24/8/202312:15EDGAR2Form DEFC14A - Definitive proxy statement, contested..
23/8/202322:47EDGAR2Form SC 13D - General statement of acquisition of beneficial..
17/8/202315:30EDGAR2Form PRRN14A - Non-management revised preliminary proxy..
15/8/202323:15EDGAR2Form SC 13D/A - General statement of acquisition of..
14/8/202323:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202315:20EDGAR2Form SC 13D/A - General statement of acquisition of..
04/8/202322:21EDGAR2Form 8-K - Current report
03/8/202322:31EDGAR2Form SC 13D/A - General statement of acquisition of..
03/8/202300:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/8/202300:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/8/202323:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/8/202323:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/8/202323:28EDGAR2Form PREC14A - Preliminary proxy statements, contested..
01/8/202322:06EDGAR2Form 8-K - Current report
06/7/202322:08EDGAR2Form SC 13D/A - General statement of acquisition of..

Dernières Valeurs Consultées

NASDAQ
FBRX
Forte Biosciences
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés